$INCY
INCYTE CORP Stock $incy

$incy Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000104746914001174 Filed on February 21, 2014

Income Statement

Concept	2014 Q1	2013 Q4	2013 Q3
Revenue	$89.79M	$97.07M	$85.12M
YoY Change	26.33%	-14.73%	40.72%
Cost Of Revenue	$168.0K	$200.0K	$155.0K
YoY Change	12.0%	100.0%	400.0%
Gross Profit	$89.62M	$96.90M	$84.97M
YoY Change	26.36%	-14.78%	40.53%
Gross Profit Margin	99.81%	99.82%	99.82%
Selling, General & Admin	$36.97M	$38.00M	$26.45M
YoY Change	66.09%	60.34%	28.88%
% of Gross Profit	41.25%	39.22%	31.13%
Research & Development	$75.59M	$75.00M	$71.70M
YoY Change	43.25%	25.42%	43.18%
% of Gross Profit	84.34%	77.4%	84.39%
Depreciation & Amortization	$9.623M	$8.800M	$4.600M
YoY Change	24.42%	12.82%	-39.47%
% of Gross Profit	10.74%	9.08%	5.41%
Operating Expenses	$112.6M	$113.0M	$98.15M
YoY Change	50.03%	35.33%	39.03%
Operating Profit	-$22.94M	-$16.10M	-$13.18M
YoY Change	459.8%	-153.31%	30.04%
Interest Expense	$11.44M	-$8.400M	$7.699M
YoY Change	-2.43%	-26.32%	-33.47%
% of Operating Profit
Other Income/Expense, Net	-$300.0K	-$200.0K	-$1.500M
YoY Change
Pretax Income	-$33.91M	-$42.70M	-$21.99M
YoY Change	117.0%	-325.93%	1.4%
Income Tax	$49.00K	$100.0K	$49.00K
% Of Pretax Income
Net Earnings	-$34.00M	-$42.90M	-$22.00M
YoY Change	116.56%	-328.19%	1.38%
Net Earnings / Revenue	-37.87%	-44.19%	-25.84%
Basic Earnings Per Share
Diluted Earnings Per Share	-$205.6K	-$265.0K	-$141.8K
COMMON SHARES
Basic Shares Outstanding	165.5M shares	161.1M shares	153.1M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2013 Q4	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$519.2M	$509.0M	$291.2M
YoY Change	92.15%	122.85%	19.54%
Cash & Equivalents	$436.6M	$471.4M	$272.1M
Short-Term Investments	$82.60M	$37.60M	$19.10M
Other Short-Term Assets	$15.20M	$11.00M	$9.000M
YoY Change	42.06%	11.11%	-51.09%
Inventory	$347.0K	$406.0K	$359.0K
Prepaid Expenses
Receivables	$46.40M	$35.40M	$33.20M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$581.2M	$555.8M	$333.7M
YoY Change	88.01%	79.57%	19.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$38.65M	$26.85M	$6.201M
YoY Change	496.05%	322.94%	0.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$29.90M	$29.40M	$14.90M
YoY Change	228.57%	245.88%	198.0%
Total Long-Term Assets	$85.66M	$73.77M	$23.66M
YoY Change	304.63%	252.88%	32.85%
TOTAL ASSETS
Total Short-Term Assets	$581.2M	$555.8M	$333.7M
Total Long-Term Assets	$85.66M	$73.77M	$23.66M
Total Assets	$666.8M	$629.6M	$357.4M
YoY Change	101.9%	90.54%	20.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.95M	$19.10M	$18.21M
YoY Change	15.69%	36.82%	42.68%
Accrued Expenses	$56.95M	$46.06M	$41.74M
YoY Change	78.66%	62.28%	83.48%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$106.9M	$108.0M	$109.5M
YoY Change	-11.82%	-20.6%	-20.45%
LONG-TERM LIABILITIES
Long-Term Debt	$665.2M	$681.5M	$187.1M
YoY Change	97.1%	105.83%	-42.4%
Other Long-Term Liabilities	$34.04M	$26.80M	$3.392M
YoY Change	-2.75%	-29.84%	-93.73%
Total Long-Term Liabilities	$34.04M	$26.80M	$3.392M
YoY Change	-90.86%	-92.74%	-99.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$106.9M	$108.0M	$109.5M
Total Long-Term Liabilities	$34.04M	$26.80M	$3.392M
Total Liabilities	$829.2M	$822.7M	$328.6M
YoY Change	67.93%	62.78%	-36.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.771B	-$1.737B	-$1.694B
YoY Change	6.08%	5.03%	1.29%
Common Stock	$1.607B	$1.542B	$1.721B
YoY Change	6.81%	4.39%	18.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$162.4M	-$193.1M	$28.79M
YoY Change
Total Liabilities & Shareholders Equity	$666.8M	$629.6M	$357.4M
YoY Change	101.9%	90.54%	20.53%

Cashflow Statement

Concept	2014 Q1	2013 Q4	2013 Q3
OPERATING ACTIVITIES
Net Income	-$34.00M	-$42.90M	-$22.00M
YoY Change	116.56%	-328.19%	1.38%
Depreciation, Depletion And Amortization	$9.623M	$8.800M	$4.600M
YoY Change	24.42%	12.82%	-39.47%
Cash From Operating Activities	-$31.70M	-$11.70M	-$11.90M
YoY Change	-228.34%	-46.82%	-56.09%
INVESTING ACTIVITIES
Capital Expenditures	-$2.700M	-$2.100M	-$800.0K
YoY Change	200.0%	133.33%	100.0%
Acquisitions
YoY Change
Other Investing Activities	-$45.00M	-$17.90M	-$200.0K
YoY Change	-45100.0%	-3680.0%	-300.0%
Cash From Investing Activities	-$47.70M	-$19.90M	-$1.000M
YoY Change	5862.5%	3880.0%	233.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	44.50M	230.9M	26.90M
YoY Change	150.0%	2978.67%	202.25%
NET CHANGE
Cash From Operating Activities	-31.70M	-11.70M	-11.90M
Cash From Investing Activities	-47.70M	-19.90M	-1.000M
Cash From Financing Activities	44.50M	230.9M	26.90M
Net Change In Cash	-34.90M	199.3M	14.00M
YoY Change	-183.69%	-1428.67%	-175.68%
FREE CASH FLOW
Cash From Operating Activities	-$31.70M	-$11.70M	-$11.90M
Capital Expenditures	-$2.700M	-$2.100M	-$800.0K
Free Cash Flow	-$29.00M	-$9.600M	-$11.10M
YoY Change	-213.28%	-54.5%	-58.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9867000	USD
CY2013Q4	us-gaap	Assets Assets	629568000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	224057000	USD
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4361000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	309514000	USD
CY2012Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	8475000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6348000	USD
CY2012Q4	incy	Intangible And Other Assets Net IntangibleAndOtherAssetsNet	6082000	USD
CY2012Q4	us-gaap	Assets Assets	330419000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13961000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22899000	USD
CY2012Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4750000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28385000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	108042000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	822676000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q2	dei	Entity Public Float EntityPublicFloat	3000000000	USD
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	165536632	shares
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2012Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	70951000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	278000	USD
CY2012Q4	incy	Deferred Collaborative Agreements Revenue Current DeferredCollaborativeAgreementsRevenueCurrent	66079000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	136074000	USD
CY2012Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	322043000	USD
CY2012Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	9033000	USD
CY2012Q4	incy	Deferred Collaborative Agreements Revenue Noncurrent DeferredCollaborativeAgreementsRevenueNoncurrent	38226000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	505376000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	133000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1476922000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1878000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1653890000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	555799000	USD
CY2013Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	500000	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	133462185	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	133462185	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	162984680	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	162984680	shares
CY2011	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2012000	USD
CY2011	us-gaap	Contracts Revenue ContractsRevenue	91948000	USD
CY2012	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	458000	USD
CY2012	us-gaap	Revenues Revenues	297059000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	210391000	USD
CY2011	us-gaap	Investment Income Net InvestmentIncomeNet	462000	USD
CY2012	us-gaap	Interest Expense InterestExpense	46058000	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44320000	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-186540000	USD
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.34
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.49
CY2012	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	136001000	USD
CY2012	us-gaap	Royalty Revenue RoyaltyRevenue	3652000	USD
CY2012	us-gaap	Contracts Revenue ContractsRevenue	156948000	USD
CY2011	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	495000	USD
CY2011	us-gaap	Revenues Revenues	94455000	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	157000	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	178707000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	85363000	USD
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	58219000	USD
CY2011	us-gaap	Other General Expense OtherGeneralExpense	712000	USD
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	295911000	USD
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	237638000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	1148000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-143183000	USD
CY2012	us-gaap	Investment Income Net InvestmentIncomeNet	764000	USD
CY2011	us-gaap	Interest Expense InterestExpense	43819000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-44146000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-186540000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	174000	USD
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	148403000	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	129747000	shares
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	125362000	shares
CY2013	us-gaap	Revenues Revenues	354947000	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	371049000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-16102000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-82848000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-83147000	USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.56
CY2013	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	11484000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	788000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-159000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax	-552000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax	-185000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	236000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-344000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44084000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-186884000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83032000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	115000	USD
CY2011	us-gaap	Restructuring Costs RestructuringCosts	-88000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29979000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26990000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	38493000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	28983000	USD
CY2012	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	552000	USD
CY2011	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-185000	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	64536000	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	714000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-16903000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-17824000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5217000	USD
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3536000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-978000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4166000	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4668000	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	15633000	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2332000	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2332000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-94830000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2501000	USD
CY2012	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	47711000	USD
CY2011	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	19468000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	47711000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	19468000	USD
CY2012	incy	Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan	47711000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	417912000	USD
CY2011	incy	Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan	19468000	USD
CY2012	us-gaap	Interest Paid InterestPaid	19000000	USD
CY2011	us-gaap	Interest Paid InterestPaid	19000000	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	1000	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	140000	USD
CY2013	us-gaap	Interest Paid InterestPaid	15587000	USD
CY2013	incy	Stock Issued During Period Value Stock Options And Restricted Stock Units Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsExercisedAndEmployeeStockPurchasePlan	73157000	USD
CY2012	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	10000000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29207000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38493000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	28983000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38398000	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	154338000	USD
CY2013	incy	Stock Issued During Period Shares Stock Options And Restricted Stock Units Exercised StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsExercised	6898551	shares
CY2012	incy	Stock Issued During Period Shares Stock Options And Restricted Stock Units Exercised StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsExercised	5150649	shares
CY2011	incy	Stock Issued During Period Shares Stock Options And Restricted Stock Units Exercised StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsExercised	2294586	shares
CY2013	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	390000	shares
CY2012	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	378041	shares
CY2011	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	896939	shares
CY2012	incy	Increase Decrease Deferred Revenue Collaborative Agreements IncreaseDecreaseDeferredRevenueCollaborativeAgreements	-66938000	USD
CY2011	incy	Increase Decrease Deferred Revenue Collaborative Agreements IncreaseDecreaseDeferredRevenueCollaborativeAgreements	-66950000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-161715000	USD
CY2012	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2839000	USD
CY2011	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	3799000	USD
CY2012	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	-9000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1988000	USD
CY2012	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-49107000	USD
CY2011	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-144748000	USD
CY2013	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	247372000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	275589000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-37397000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	9180000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	471429000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	273164000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	-88644000	USD
CY2013Q2	incy	Grant Receivable Related To Retention And Expansion Of Workforce Maximum GrantReceivableRelatedToRetentionAndExpansionOfWorkforceMaximum	11100000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	-227077000	USD
CY2013	incy	Credit Exposure Limitation Number Of Issuer Other Than United States Government Guaranteed Securities CreditExposureLimitationNumberOfIssuerOtherThanUnitedStatesGovernmentGuaranteedSecurities	1	item
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-ALIGN: justify; FONT-FAMILY: times;"><font size="2"><i>        Use of Estimates.</i></font><font size="2">    The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></p> </div>
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-ALIGN: justify; FONT-FAMILY: times;"><font size="2"><i>        Concentrations of Credit Risk.</i></font><font size="2">    Cash, cash equivalents, marketable securities, trade receivables and restricted investments are financial instruments which potentially subject us to concentrations of credit risk. The estimated fair value of financial instruments approximates the carrying value based on available market information. We primarily invest our excess available funds in notes and bills issued by the U.S. government and its agencies and corporate debt securities and, by policy, limit the amount of credit exposure to any one issuer and to any one type of investment, other than securities issued or guaranteed by the U.S. government. Our receivables mainly relate to our product sales of JAKAFI and collaborative agreements with pharmaceutical companies. We have not experienced any significant credit losses on cash, cash equivalents, marketable securities, trade receivables or restricted investments to date and do not require collateral on receivables.</font></p> </div>
CY2013	incy	Proceeds From Grant Related To Retention And Expansion Of Workforce ProceedsFromGrantRelatedToRetentionAndExpansionOfWorkforce	10600000	USD
CY2013	incy	Minimum Unrealized Loss Position For Marketable Securities To Be Classified As Long Term MinimumUnrealizedLossPositionForMarketableSecuritiesToBeClassifiedAsLongTerm	P6M
CY2013Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	37575000	USD
CY2013	incy	Holding Period For Recovery Of Unrealized Loss Position For Long Term Investments HoldingPeriodForRecoveryOfUnrealizedLossPositionForLongTermInvestments	P1Y
CY2013	incy	Inventory Finished Goods Useful Life Minimum InventoryFinishedGoodsUsefulLifeMinimum	P24M
CY2013	incy	Inventory Finished Goods Useful Life Maximum InventoryFinishedGoodsUsefulLifeMaximum	P36M
CY2013	incy	Percentage Of Medi Care Part D Insurance Coverage Gap Required To Be Funded By Manufacturers PercentageOfMediCarePartDInsuranceCoverageGapRequiredToBeFundedByManufacturers	0.50	pure
CY2013	incy	Category Of Milestone Events Number CategoryOfMilestoneEventsNumber	3	item
CY2013	incy	Number Of Stages Of Life Cycle Drugs NumberOfStagesOfLifeCycleDrugs	3	item
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38400000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38500000	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29000000	USD
CY2012	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	600000	USD
CY2011	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	200000	USD
CY2013	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
CY2013Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	591000	USD
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14346000	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	591000	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7884000	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	406000	USD
CY2013Q4	incy	Inventory Net Current And Noncurrent InventoryNetCurrentAndNoncurrent	15343000	USD
CY2012Q4	incy	Inventory Net Current And Noncurrent InventoryNetCurrentAndNoncurrent	8753000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	406000	USD
CY2013Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	14937000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36004000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	59321000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	32473000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	29656000	USD
CY2013	incy	Depreciation And Amortization Excluding Amortization Of Intangible Assets DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets	3200000	USD
CY2012	incy	Depreciation And Amortization Excluding Amortization Of Intangible Assets DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets	2900000	USD
CY2011	incy	Depreciation And Amortization Excluding Amortization Of Intangible Assets DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets	2200000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26848000	USD
CY2012Q4	incy	Intangible And Other Assets Gross IntangibleAndOtherAssetsGross	12897000	USD
CY2012Q4	incy	Intangible And Other Assets Accumulated Amortization IntangibleAndOtherAssetsAccumulatedAmortization	6815000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2200000	USD
CY2013Q4	incy	Intangible And Other Assets Gross IntangibleAndOtherAssetsGross	19824000	USD
CY2013Q4	incy	Intangible And Other Assets Accumulated Amortization IntangibleAndOtherAssetsAccumulatedAmortization	2340000	USD
CY2013Q4	incy	Intangible And Other Assets Net IntangibleAndOtherAssetsNet	17484000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1700000	USD
CY2013Q4	us-gaap	Preferred Stock Capital Shares Reserved For Future Issuance PreferredStockCapitalSharesReservedForFutureIssuance	21222357	shares
CY2013Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	35374000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9620000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19102000	USD
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	20123089	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed	Black-Scholes valuation model
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	21000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	23000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	9000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	704000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	627000000	USD
CY2013Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1500000000	USD
CY2013	incy	Aggregate Ownership Percentage Change Minimum AggregateOwnershipPercentageChangeMinimum	0.50	pure
CY2013	incy	Testing Period For Ownership Change TestingPeriodForOwnershipChange	P3Y
CY2013	incy	Adjustment To Additional Paid In Capital When Deferred Tax Assets Related To Equity Compensation Is Realized AdjustmentToAdditionalPaidInCapitalWhenDeferredTaxAssetsRelatedToEquityCompensationIsRealized	131200000	USD
CY2013Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	121700000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-28997000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	18215000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	6645000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1253000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	299000	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-15451000	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	6492000	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	8347000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	410000	USD
CY2011	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-65289000	USD
CY2011	us-gaap	Income Tax Reconciliation Tax Contingencies Other IncomeTaxReconciliationTaxContingenciesOther	57102000	USD
CY2011	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	7612000	USD
CY2011	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	235000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	513000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	122000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	8000000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	77000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	493000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	96000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	14000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	44000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	22000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	677000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	677000000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	200	USD
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-50000000	USD
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-16000000	USD
CY2011	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	72000000	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	45620469	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	68426292	shares
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	70067756	shares
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1900000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1700000	USD
CY2011	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	900000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	6400000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	6100000	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5800000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	5600	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	200	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	200	USD
CY2013Q1	us-gaap	Revenues Revenues	71077000	USD
CY2013Q2	us-gaap	Revenues Revenues	101675000	USD
CY2013Q3	us-gaap	Revenues Revenues	85123000	USD
CY2013Q4	us-gaap	Revenues Revenues	97072000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15669000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2571000	USD
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22037000	USD
CY2013Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-42870000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	134345000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	142284000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	155067000	shares
CY2013Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	161914000	shares
CY2012Q1	us-gaap	Revenues Revenues	36179000	USD
CY2012Q2	us-gaap	Revenues Revenues	86542000	USD
CY2012Q3	us-gaap	Revenues Revenues	60492000	USD
CY2012Q4	us-gaap	Revenues Revenues	113845000	USD
CY2012Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45426000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4037000	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21710000	USD
CY2012Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	18779000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127203000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127203000	shares
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	129224000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	137969000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130851000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130851000	shares
CY2012Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139118000	shares
CY2012Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131711000	shares
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	100	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	5800	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	-8000000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	-69000000	USD
CY2013	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9373000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	38398000	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	846600000	USD
CY2013	incy	Credit Exposure Limitation Number Of Financial Investment Other Than United States Government Guaranteed Securities CreditExposureLimitationNumberOfFinancialInvestmentOtherThanUnitedStatesGovernmentGuaranteedSecurities	1	item
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-35577000	USD
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	12474119	shares
CY2013	incy	Square Footage Of Laboratory And Office On Lease SquareFootageOfLaboratoryAndOfficeOnLease	190000
CY2013	incy	Facility Lease Term FacilityLeaseTerm	P15Y
CY2013	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	500000	USD
CY2013	incy	Operating Leases Initial Term Of Lease Over Which Specified Minimum Lease Rental Is Payable OperatingLeasesInitialTermOfLeaseOverWhichSpecifiedMinimumLeaseRentalIsPayable	P10Y
CY2013	incy	Improvements Cost Payable ImprovementsCostPayable	10800000	USD
CY2013	incy	Letter Of Credit For Issued For Lease Facility LetterOfCreditForIssuedForLeaseFacility	15000000	USD
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	278000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	2483000	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	35582000	USD
CY2013Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	2023000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1878000	USD
CY2013Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	30000	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	4361000	USD
CY2013Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	37575000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	96600000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	375000000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	375000000	USD
CY2013	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	499994000	USD
CY2013	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	728696000	USD
CY2013	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument	-17934000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	28079000	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1909000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	46062000	USD
CY2013Q4	incy	Deferred Collaborative Agreements Revenue Current DeferredCollaborativeAgreementsRevenueCurrent	12890000	USD
CY2013Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	661567000	USD
CY2013Q4	incy	Deferred Collaborative Agreements Revenue Noncurrent DeferredCollaborativeAgreementsRevenueNoncurrent	25369000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	163000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1541773000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1993000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1737037000	USD
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	235443000	USD
CY2013	us-gaap	Royalty Revenue RoyaltyRevenue	28251000	USD
CY2013	us-gaap	Contracts Revenue ContractsRevenue	91047000	USD
CY2013	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	206000	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	630000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	260436000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	109983000	USD
CY2013	us-gaap	Investment Income Net InvestmentIncomeNet	1324000	USD
CY2013	us-gaap	Interest Expense InterestExpense	38652000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	115000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-247000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6590000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5141000	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	27189000	USD
CY2013	incy	Increase Decrease Deferred Revenue Collaborative Agreements IncreaseDecreaseDeferredRevenueCollaborativeAgreements	-66046000	USD
CY2013	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4267000	USD
CY2013	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	73157000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	14500000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26803000	USD
CY2013	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-15000000	USD
CY2013	incy	Payment In Connection Of Conversion Of Convertible Debt PaymentInConnectionOfConversionOfConvertibleDebt	11484000	USD
CY2013	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	19274000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	500	USD
CY2013	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	2	item
CY2013Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	19900000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	214000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-5549000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2013	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	33713000	USD
CY2012	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-860000	USD
CY2011	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-1298000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	895000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	895000	USD
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	214000	USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	583000	USD
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	214000	USD
CY2013Q4	incy	Royalty Payment Receivable RoyaltyPaymentReceivable	8300000	USD
CY2012Q4	incy	Royalty Payment Receivable RoyaltyPaymentReceivable	3300000	USD
CY2013	incy	Operating Leases Remaining Term Of Lease Over Which Specified Minimum Lease Rentals Payable OperatingLeasesRemainingTermOfLeaseOverWhichSpecifiedMinimumLeaseRentalsPayable	P5Y
CY2013Q4	incy	Direct Financing Future Minimum Payments Due Current DirectFinancingFutureMinimumPaymentsDueCurrent	10200	USD
CY2013Q4	incy	Direct Financing Future Minimum Payments Due In Two Years DirectFinancingFutureMinimumPaymentsDueInTwoYears	5400	USD
CY2013Q4	incy	Direct Financing Future Minimum Payments Due In Three Years DirectFinancingFutureMinimumPaymentsDueInThreeYears	5400	USD
CY2013Q4	incy	Direct Financing Future Minimum Payments Due In Four Years DirectFinancingFutureMinimumPaymentsDueInFourYears	5400	USD
CY2013Q4	incy	Direct Financing Future Minimum Payments Due In Five Years DirectFinancingFutureMinimumPaymentsDueInFiveYears	5400	USD
CY2013Q4	incy	Direct Financing Future Minimum Payments Due Thereafter DirectFinancingFutureMinimumPaymentsDueThereafter	63000	USD
CY2013Q4	incy	Direct Financing Future Minimum Payments Due DirectFinancingFutureMinimumPaymentsDue	94800	USD
CY2013	incy	Income Tax Reconciliation Nondeductible Expense Interest IncomeTaxReconciliationNondeductibleExpenseInterest	747000	USD
CY2012	incy	Income Tax Reconciliation Nondeductible Expense Interest IncomeTaxReconciliationNondeductibleExpenseInterest	376000	USD
CY2011	incy	Income Tax Reconciliation Nondeductible Expense Interest IncomeTaxReconciliationNondeductibleExpenseInterest	340000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	7985000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	8000000	USD
CY2013Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	-77000000	USD
CY2013	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	item
CY2013Q4	incy	Tax Credit Carryforward Additional Amount TaxCreditCarryforwardAdditionalAmount	5500000	USD

Files In Submission

Name	View Source	Status
0001047469-14-001174-index-headers.html	Edgar Link	pending
0001047469-14-001174-index.html	Edgar Link	pending
0001047469-14-001174.txt	Edgar Link	pending
0001047469-14-001174-xbrl.zip	Edgar Link	pending
a2218324z10-k.htm	Edgar Link	pending
a2218324zex-10_21.htm	Edgar Link	pending
a2218324zex-10_24.htm	Edgar Link	pending
a2218324zex-10_27.htm	Edgar Link	pending
a2218324zex-12_1.htm	Edgar Link	pending
a2218324zex-23_1.htm	Edgar Link	pending
a2218324zex-31_1.htm	Edgar Link	pending
a2218324zex-31_2.htm	Edgar Link	pending
a2218324zex-32_1.htm	Edgar Link	pending
a2218324zex-32_2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g263273la15i001.jpg	Edgar Link	pending
g263273la53i001.jpg	Edgar Link	pending
g263273la55i001.jpg	Edgar Link	pending
incy-20131231.xml	Edgar Link	completed
incy-20131231.xsd	Edgar Link	pending
incy-20131231_cal.xml	Edgar Link	unprocessable
incy-20131231_def.xml	Edgar Link	unprocessable
incy-20131231_lab.xml	Edgar Link	unprocessable
incy-20131231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INCY
INCYTE CORP Stock $incy

2014 Q1 Form 10-K Financial Statement

#000104746914001174 Filed on February 21, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INCY INCYTE CORP Stock $incy

2014 Q1 Form 10-K Financial Statement

#000104746914001174 Filed on February 21, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INCY
INCYTE CORP Stock $incy